Effects of a Therapy With INTRAVIT® Tablets in Patients With Diabetic Retinopathy

Inclusion Criteria: * Diabetes type I and type II patients; * Between 20 and 70 years of age; * Age of diabetes not less than 5 years and not more than 15; * Mild non-proliferating diabetic retinopathy, limited to the presence of some microaneurysms; * Patients in diabetic compensation; * Visual acuity 5/10 natural or correct; * Patients even if hypertensive, with or without anti-hypertensive therapy in place, provided they are compensated; * Patients with good visualization of the ocular fundus. Exclusion Criteria: * Patients with concurrent eye diseases outside diabetic retinopathy; * Patients with less than natural or correct 5/10 visual acuity; * Patients treated with other vasoprotective and antioxidant preparations or having taken them in the last month; * Patients with significant systemic or metabolic diseases, except diabetes; * Patients with unbalanced Diabetes disorder; * Patients undergoing laser treatment or eye surgery (e.g. cataract); * Patients who take or should take, during the observation period, preparations for direct or indirect activity on the retina of the type that can be superimposed on INTRAVIT ®.